Инструкция по применению MOBILISIN
Содержание инструкции
MOBILISIN 40 g Cream
Flufenamic acid + Ethylene glycol monosalicylate + Glycosaminoglycan polysulphate
Read this leaflet carefully before using this medicine as it contains important
information for you.
Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you.
- Keep this leaflet. You may need to read it again.
- If you want more information or advice, ask your pharmacist.
- If any side effects occur, including those not listed in this leaflet, tell your doctor or pharmacist. See section 4.
- See a doctor if you do not feel better or if you feel worse.
Contents of this leaflet:
- 1. What MOBILISIN is and what it is used for
- 2. What you need to know before using MOBILISIN
- 3. How to use MOBILISIN
- 4. Possible side effects
- 5. How to store MOBILISIN
- 6. Contents of the pack and other information
1. What is MOBILISIN and what is it used for
MOBILISIN belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs),
used to relieve pain and inflammation.
MOBILISIN is used in adults to treat local pain and inflammation of muscles, tendons, ligaments and joints.
It is also indicated for the treatment of muscle tension, back pain, neck stiffness, neuralgia, sciatica.
2. What you need to know before using MOBILISIN
Do not use MOBILISIN
- if you are allergic to the active ingredients or to any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
- Consult your doctor or pharmacist before using MOBILISIN if you suffer from kidney failure.
- Avoid exposure to sunlight of the areas treated with the cream.
- DO NOT USE the cream on burns, infections or other skin diseases.
- Prolonged use may cause skin reactions. Stop treatment immediately and consult your doctor if an allergic reaction occurs after applying the cream.
- If the medicine is used on large areas of skin and for a prolonged period, the possibility of systemic side effects (which can affect different parts of the body) cannot be excluded (see section 4 “Possible side effects”).
Children
No data are available on efficacy and safety in this population. Therefore, do not use MOBILISIN in children.
Other medicines and MOBILISIN
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
In particular, tell your doctor if you are taking any of the following medicines:
- methotrexate (a medicine used to treat some types of cancer)
- sulfonylureas (e.g. glimepiride, gliclazide, medicines used to treat diabetes).
Pregnancy and breastfeeding
If you are pregnant, suspect you are pregnant or are planning to become pregnant, or if you are breastfeeding, ask your doctor or pharmacist for advice before using this medicine.
During pregnancy and breastfeeding, you may only use this medicine if considered strictly necessary by your doctor, under his/her direct supervision, and only for a short period of treatment.
Driving and operating machinery
No known effects.
MOBILISIN contains sorbic acid
Sorbic acidmay cause local skin reactions (e.g. contact dermatitis).
3. How to use MOBILISIN
Use this medicine following exactly as stated in this leaflet or as instructed by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist.
The recommended dose is a thread of cream of 5-10 cm, depending on the extent of the area to be treated, several times
a day.
If necessary, after consulting your doctor, you can also use MOBILISIN for prolonged periods of
time.
Method of use:
- Massage gently to promote absorption.
- After application, wash your hands, otherwise they will also be treated with the cream.
- Do not bring into contact with eyes or mucous membranes.
- Do not ingest.
If you use more MOBILISIN than you should
In case of taking an excessive dose of MOBILISIN, wash the treated area thoroughly with running water
and contact your doctor immediately.
If you have any doubts about the use of this medicine, consult your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If the medicine is used on large areas of skin and for a prolonged period, the possibility of systemic side effects (which may affect different parts of the body) such as gastrointestinal disorders, nausea, headache, dizziness and general malaise cannot be excluded; if you notice any of these symptoms, stop treatment and consult your doctor.
Rare side effects (may affect up to 1 in 1000 people):
- skin irritation or erythema
- itching
- skin rashes
- increased skin sensitivity to sunlight. Usually these symptoms disappear with discontinuation of treatment.
Reporting of side effects
If you get any side effects, even those not listed in this leaflet, tell your doctor
or pharmacist. You can also report side effects directly through the national system
at www.agenziafarmaco.gov.it/it/responsabili .
By reporting side effects you can help provide more information on the safety of this
medicine.
5. How to store MOBILISIN
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the pack after Exp. The expiry date refers to the last day of that month.
Do not dispose of any medicine in waste water or household waste. Ask your pharmacist how to dispose of medicines you no longer use. This will help protect the environment.
6. Contents of the pack and other information
What MOBILISIN contains
- The active ingredients are flufenamic acid, ethylene glycol monosalicylate, glycosaminoglycan polysulphate. 100 g of cream contain 3.0 g of flufenamic acid, 2.64 g of ethylene glycol monosalicylate and 0.20 g of glycosaminoglycan polysulphate
- The other ingredients are mono- and di-glycerides of fatty acids, sodium salts of fatty alcohol sulphonates, triglycerides of vegetable fatty acids, myristyl alcohol, aluminium and magnesium silicate, 25% hydrochloric acid, sorbic acid, isopropyl alcohol, rosemary oil, lemon balm oil, purified water.
Description of the appearance of MOBILISIN and contents of the pack
Cutaneous cream for external use.
MOBILISIN is available in packs containing 40 g of cream in an aluminium tube.
Marketing Authorisation Holder
EG S.p.A., Via Pavia, 6 – 20136 Milan
Manufacturer
Mobilat Produktions Gmbh, Luitpoldstrasse, 1 - 85276 - Pfaffenhofen (Germany)
Stada Arzneimittel AG, Stadastrasse 2-18, 61118 Bad Vilbel (Germany)

- Страна регистрации
- Форма выпускаCream, 40 G
- Отпускается по рецептуНет
- Производитель
- Информация на этой странице носит справочный характер и не является медицинской консультацией. Перед началом приема лекарства обязательно проконсультируйтесь с врачом.
- Аналоги MOBILISINФорма выпуска: Gel, 10 MG/GДействующее вещество: ДиклофенакПроизводитель: SIGILLATA LIMITEDОтпускается без рецептаФорма выпуска: Cream, 3%Действующее вещество: benzydamineОтпускается без рецептаФорма выпуска: Cutaneous spray, solution, 40 MG/MLДействующее вещество: ДиклофенакПроизводитель: FARMALIDER SAОтпускается без рецепта
Аналоги MOBILISIN в других странах
Лекарства с тем же действующим веществом, доступные в других странах.
Аналог MOBILISIN в Украина
Аналог MOBILISIN в Испания
Врачи онлайн по MOBILISIN
Обсудите применение MOBILISIN и возможные следующие шаги — по оценке врача.
Получите рецепт на MOBILISIN онлайн
Заполните форму за 2 минуты
Расскажите о симптомах, истории болезни и нужном препарате.
Выберите врача или мы назначим
Выберите специалиста или мы подберём ближайшего доступного врача.
Врач рассматривает ваш случай
Обычно в течение 30 минут. Может задать уточняющие вопросы в чате.
Получите в любой аптеке
Электронный рецепт отправляется на вашу почту — действителен по всей Польше.
Часто задаваемые вопросы
MOBILISIN не требует рецепта в Италия. Вы можете уточнить у врача онлайн, подходит ли это лекарство для вашей ситуации.
MOBILISIN производится компанией EG S.P.A.. Упаковка и торговое название могут отличаться в зависимости от дистрибьютора.
Врачи, включая Семейные врачи, Психиатры, Дерматологи, Кардиологи, Эндокринологи, Гастроэнтерологи, Пульмонологи, Нефрологи, Ревматологи, Гематологи, Инфекционисты, Аллергологи, Гериатры, Педиатры, Онкологи, могут оценить целесообразность применения MOBILISIN с учетом вашей ситуации и местных правил. Вы можете записаться на онлайн-консультацию, чтобы обсудить возможные варианты.
Польша имеет хорошо развитую систему здравоохранения в крупных городах, таких как Варшава, Краков, Вроцлав и Гданьск. Аптеки широко доступны и работают в соответствии с действующим законодательством, обеспечивая доступ к рецептурным препаратам.
Вы можете купить MOBILISIN в Варшаве, Кракове, Вроцлаве или Гданьске в любой аптеке при наличии действующего рецепта.
Чтобы получить рецепт, вы можете воспользоваться Oladoctor:
Другие лекарства с тем же действующим веществом () включают ATLIMARBAI, BENTSIDAMINA AKRAF, BREXIADVANKE. Они могут отличаться торговым названием или формой выпуска, но содержат одинаковый терапевтический компонент. Перед изменением лечения рекомендуется проконсультироваться с врачом.
















